Literature DB >> 17510319

Benzodiazepine withdrawal-induced glutamatergic plasticity involves up-regulation of GluR1-containing alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in Hippocampal CA1 neurons.

Jun Song1, Guofu Shen, L John Greenfield, Elizabeth I Tietz.   

Abstract

Modification of glutamatergic synaptic function, a mechanism central to neuronal plasticity, may also mediate long-term drug effects, including dependence and addiction. Benzodiazepine withdrawal results in increased glutamatergic strength, but whether alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors (AMPARs) are functionally and structurally remodeled during benzodiazepine withdrawal is uncertain. Whole-cell recordings of rat hippocampal CA1 neurons, either acutely dissociated or in hippocampal slices, revealed that AMPAR function was enhanced up to 50% during flurazepam (FZP) withdrawal, without changes in whole-cell channel kinetic properties. Agonist-elicited AMPA currents showed a negative shift in rectification in the presence of spermine, suggesting augmented membrane incorporation of glutamate receptor (GluR) 2-lacking AMPARs. As GluR1-containing AMPARs are critical for activity-dependent alterations in excitatory strength, we sought to determine whether changes in GluR1 subunit distribution in CA1 neurons occurred during benzodiazepine withdrawal. Confocal image analysis revealed that FZP withdrawal promoted GluR1 subunit incorporation into somatic and proximal dendritic membranes of CA1 neurons without GluR2 subunit alterations. Findings of immunoblot studies were consistent with immunofluorescent studies indicating increased GluR1, but not GluR2, subunit protein levels in cytosolic, crude membrane and postsynaptic density-enriched fractions from CA1 minislices. As with long-term potentiation (LTP), the FZP-withdrawal-induced GluR1 incorporation into CA1 neuron membranes may require the GluR1-trafficking protein, synapse-associated protein 97, which was also elevated in membrane-associated fractions. Together, our findings provide evidence that during FZP withdrawal, increased membrane incorporation of GluR1-containing AMPARs and associated up-regulation of AMPAR functions in hippocampal CA1 pyramidal neurons share fundamental similarities with the mechanisms underlying LTP. This implies that glutamatergic neuronal remodeling observed in LTP also subserves physiological adaptations to drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510319     DOI: 10.1124/jpet.107.121798

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca²⁺-permeable AMPA receptors during the incubation of cocaine craving.

Authors:  Carrie R Ferrario; Jessica A Loweth; Mike Milovanovic; Kerstin A Ford; Gregorio L Galiñanes; Li-Jun Heng; Kuei Y Tseng; Marina E Wolf
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

2.  Chronic benzodiazepine-induced reduction in GABA(A) receptor-mediated synaptic currents in hippocampal CA1 pyramidal neurons prevented by prior nimodipine injection.

Authors:  K Xiang; E I Tietz
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

3.  Calcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.

Authors:  Guofu Shen; Bradley J Van Sickle; Elizabeth I Tietz
Journal:  Neuropsychopharmacology       Date:  2010-05-05       Impact factor: 7.853

Review 4.  Glutamate plasticity in the drunken amygdala: the making of an anxious synapse.

Authors:  Brian A McCool; Daniel T Christian; Marvin R Diaz; Anna K Läck
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

Review 5.  Hooked on benzodiazepines: GABAA receptor subtypes and addiction.

Authors:  Kelly R Tan; Uwe Rudolph; Christian Lüscher
Journal:  Trends Neurosci       Date:  2011-02-25       Impact factor: 13.837

6.  Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients.

Authors:  John J Mariani; Robert J Malcolm; Agnieszka K Mamczur; Jean C Choi; Ronald Brady; Edward Nunes; Frances R Levin
Journal:  Am J Drug Alcohol Abuse       Date:  2016-03-10       Impact factor: 3.829

7.  Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A, and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal CA1 synapses during benzodiazepine withdrawal.

Authors:  Paromita Das; Ricardo Zerda; Francisco J Alvarez; Elizabeth I Tietz
Journal:  J Comp Neurol       Date:  2010-11-01       Impact factor: 3.215

8.  Down-regulation of synaptic GluN2B subunit-containing N-methyl-D-aspartate receptors: a physiological brake on CA1 neuron α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal.

Authors:  Guofu Shen; Elizabeth I Tietz
Journal:  J Pharmacol Exp Ther       Date:  2010-10-08       Impact factor: 4.030

Review 9.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

10.  Increased AMPA receptor GluR1 subunit incorporation in rat hippocampal CA1 synapses during benzodiazepine withdrawal.

Authors:  Paromita Das; Scott M Lilly; Ricardo Zerda; William T Gunning; Francisco J Alvarez; Elizabeth I Tietz
Journal:  J Comp Neurol       Date:  2008-12-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.